Filed: Jun. 13, 2018
Latest Update: Mar. 03, 2020
Summary: NOT PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _ No. 17-2955 _ LANCE YARUS, D.O., Appellant v. WALGREEN CO.; WALGREEN EASTERN CO., INC. _ APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA (D.C. Civ. Action No. 2:14-cv-01656) District Judge: Honorable C. Darnell Jones, II _ Submitted Under Third Circuit L.A.R. 34.1(a) April 16, 2018 _ Before: GREENAWAY, JR., RENDELL, and FUENTES, Circuit Judges. (Opinion Filed: June 13, 2018) _ OPINION* _
Summary: NOT PRECEDENTIAL UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT _ No. 17-2955 _ LANCE YARUS, D.O., Appellant v. WALGREEN CO.; WALGREEN EASTERN CO., INC. _ APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA (D.C. Civ. Action No. 2:14-cv-01656) District Judge: Honorable C. Darnell Jones, II _ Submitted Under Third Circuit L.A.R. 34.1(a) April 16, 2018 _ Before: GREENAWAY, JR., RENDELL, and FUENTES, Circuit Judges. (Opinion Filed: June 13, 2018) _ OPINION* _ ..
More
NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
_____________
No. 17-2955
_____________
LANCE YARUS, D.O.,
Appellant
v.
WALGREEN CO.;
WALGREEN EASTERN CO., INC.
______________
APPEAL FROM THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
(D.C. Civ. Action No. 2:14-cv-01656)
District Judge: Honorable C. Darnell Jones, II
______________
Submitted Under Third Circuit L.A.R. 34.1(a)
April 16, 2018
______________
Before: GREENAWAY, JR., RENDELL, and FUENTES, Circuit Judges.
(Opinion Filed: June 13, 2018)
______________
OPINION*
______________
*
This disposition is not an opinion of the full Court and pursuant to I.O.P. 5.7 does
not constitute binding precedent.
GREENAWAY, JR., Circuit Judge.
Appellant Dr. Lance Yarus appeals the District Court’s grant of summary judgment
in favor of appellees Walgreen Co. and Walgreen Eastern Co. Inc. (hereinafter
“Walgreens”). He contends that the District Court’s jury instructions and verdict sheet in
this defamation suit were erroneous, warranting a new trial. He also argues that the District
Court erred by finding that his claims relating to two alleged defamatory statements were
time-barred by Pennsylvania’s one-year statute of limitations. For the reasons below, we
will affirm the District Court’s rulings and orders.
I. FACTS
Dr. Yarus is an orthopedic surgeon. He brought this defamation suit in the
Philadelphia Court of Common Pleas on November 26, 2013, alleging that Walgreens’s
internal computer system, which provides pharmacists with information on prescribing
physicians, contained the comment that he was “under investigation by the [Drug
Enforcement Administration (“DEA”)],” and that certain Walgreens pharmacists repeated
this statement to his patients on five occasions. App. 6.
First, on May 1, 2009, Caroline Bailey—a patient of Dr. Yarus—went to Walgreens
and was informed by an unidentified pharmacist that Dr. Yarus was under investigation by
the DEA. Later that month, Dr. Yarus informed his then-counsel, Linda Shick, of the
incident and told her that the Walgreens pharmacist would not fill the prescriptions that he
had prescribed. Shick subsequently wrote a letter to Walgreens about the incident and
discussed the matter with Walgreens’s then-counsel, who told her that “the ‘remark’ [on
2
the prescriber profile] . . . that Dr. Yarus was under investigation by the [DEA] . . . had
been removed from the Walgreens’ computer . . . .” App. 8.
Second, on July 23, 2010, another pharmacist at Walgreens refused to fill
prescriptions for two of Dr. Yarus’s patients. Dr. Yarus contends that a handwritten note
recorded by one of Walgreens’s employees memorialized the conversation. Id. Shick then
wrote an e-mail to another of Walgreens’s counsel, Brett Stacey, to advise him of the
incident. Stacey replied with an e-mail stating that “I have confirmed all comments have
been removed.” App. 9.
Third, on March 23, 2013, pharmacist Aunnee Loi refused to fill the prescription of
another patient of Dr. Yarus, Damien Zajac. According to Zajac, Loi stated that “Dr. Yarus
is an irresponsible doctor who just writes scripts and probably does very little treating.”
App. 10. Fourth, Dr. Yarus contends that there was a publication of the defamatory
statements on June 13, 2013.
Finally, on December 20, 2013, another Walgreens pharmacist refused to fill a
prescription for another patient, Karen Gondos. According to Gondos, during her
deposition, the pharmacist told her that:
We don’t fill this doctor’s prescriptions . . . there was just
nobody going to fill it in the area – no chain stores like
Walgreen[s], CVS, Rite Aid. Nobody in the area fills his
prescription. They feel he passes out too many pain pills . . .
I’m not going to tell you that anybody is looking at him. But
the DEA wants us to report all prescriptions with him. We
can’t fill anything until we call him or he has to call us.
App. 10-11.
3
Walgreens removed the action to the United States District Court for the Eastern
District of Pennsylvania. Walgreens then moved for summary judgment, which the District
Court granted in part and denied in part. The District Court granted summary judgment on
all claims relating to the June 13, 2013 incident, finding that “[t]here is no evidence in the
record about that day.”1 App. 10. It also held that the defamation claims relating to the
May 1, 2009 and July 23, 2010 incidents were time-barred by Pennsylvania’s one-year
statute of limitations. See 42 Pa. Stat. and Cons. Stat. Ann. § 5523(1). However, the
District Court denied summary judgment as to the claims arising from the March 23, 2013
and the December 20, 2013 incidents. It found that the alleged statements from those
incidents were capable of defamatory meaning, and that there was a genuine dispute of
material fact as to whether Zajac and Gondos understood their defamatory connotation.
At trial, and regarding the March 23, 2013 incident, the District Court formulated a
question in its jury verdict sheet as follows:
If you have found that on March 23, 2013, Walgreen[s]
pharmacist Aunnee Loi made a comment to patient Damien
Zajac pertaining to plaintiff, do you find that plaintiff Lance
Yarus has proven by a preponderance of the evidence that the
comment constituted a false statement of fact, rather than a
statement of opinion.
App. 236a (Jury Verdict Sheet). Dr. Yarus did not object to this formulation. The District
Court proffered a similar question on the jury verdict sheet regarding the December 20,
2013 incident:
If you have found that a comment to patient Karen Gondos
pertaining to plaintiff was made on either December 20, 2013
1
Dr. Yarus does not challenge this holding on appeal.
4
by Walgreen[s] pharmacist Abby Rosina . . . do you find that
plaintiff Lance Yarus has proven by a preponderance of the
evidence that the statement constituted a false statement of
fact, rather than a statement of opinion.
App. 238a. Dr. Yarus also did not object to this question. At trial, Walgreens’s primary
theory of the case was that its pharmacists did not utter the alleged defamatory statements.
The jury ultimately found for Walgreens, and returned a verdict against Dr. Yarus on both
defamation claims. He timely appealed.
II. DISCUSSION2
On appeal, Dr. Yarus raises several objections to the District Court’s jury
instructions and verdict sheet, as well as to its decision to grant summary judgment on his
defamation claims relating to the May 1, 2009 and July 23, 2010 incidents. We will affirm
the District Court’s rulings and orders.
A. JURY INSTRUCTIONS
On appeal, Dr. Yarus objects to the District Court’s decision to have the jury
determine whether the alleged false statements were false statements of fact rather than
statements of opinion. Indeed, Dr. Yarus is correct that “[w]hether a particular statement
is opinion or fact is a question of law for the trial court.” Green v. Mizner, 692 A.2d 169,
174 (Pa. Super. Ct. 1997). He also contends that the jury instructions placed the burden on
him to prove falsity of the defamatory statement. However, because he did not object to
the instructions below, we must review the District Court’s decision for plain error. See
2
The District Court had jurisdiction under 28 U.S.C. § 1332(a), and we have appellate
jurisdiction pursuant to 28 U.S.C. § 1291.
5
Fed. R. Civ. P. 51(d)(1)(A) (“[A] party may assign as error: . . . an error in an instruction
actually given, if that party properly objected” (emphasis added)). Under this standard,
“we will reverse the trial court only where a plain error was ‘fundamental and highly
prejudicial, such that the instructions failed to provide the jury with adequate guidance and
our refusal to consider the issue would result in a miscarriage of justice.’” Franklin
Prescriptions, Inc. v. N.Y. Times Co., 424 F.3d 336, 339 (3d Cir. 2005) (quoting Ryder v.
Westinghouse Elec. Corp.,
128 F.3d 128, 136 (3d Cir. 1997)).
Although the questions in the verdict sheet were legally incorrect, their inclusion as
instructions to the jury did not constitute plain error. See Fashauer v. N.J. Transit Rail
Operations, Inc., 57 F.3d 1269, 1288–89 (3d Cir. 1995) (incorrect instruction as to burden
of proof in a civil case not plainly erroneous); Dunn v. HOVIC,
1 F.3d 1371, 1378 (3d Cir.
1993) (declining to consider whether jury instruction was defective under Virgin Islands
law because “th[e] issue was not properly preserved for appeal under Federal Rule of Civil
Procedure 51”). We have stated:
[W]hile ordinarily an [i]ncorrect jury instruction as to burden
of proof is fundamental and highly prejudicial and requires a
new trial, that principle assumes that the issue properly has
been preserved for appeal. . . .
We repeatedly have stressed the important policy objectives
served by Rule 51. The rule affords the trial judge an
opportunity to correct any error that may have been made in
the charge before the jury begins its deliberations. It also
lessen[s] the burden on appellate courts by diminishing the
number of rulings at the trial which they may be called upon to
review. Thus, Rule 51 is consistent with the general rule that
an appellate court will not predicate error on an issue upon
which the district court was not provided with an opportunity
to rule. We have followed this proposition strictly, and have
6
refused to consider newly developed arguments[s] concerning
[a] jury charge deficiency.
Fashauer, 57 F.3d at 1288–89 (internal quotation marks and citations omitted). We
therefore decline to grant Dr. Yarus relief because the flaws in the jury verdict sheet did
not amount to plain error.3
B. WEIGHT OF THE EVIDENCE
Dr. Yarus argues that he should be afforded a new trial because the weight of the
evidence provides that he clearly met his burden to prove that the alleged statements were
a false statement of fact and not an opinion. “[N]ew trials because the verdict is against
the weight of the evidence are proper only when the record shows that the jury’s verdict
resulted in a miscarriage of justice or where the verdict, on the record, cries out to be
overturned or shocks our conscience.” Williamson v. Consol. Rail Corp., 926 F.2d 1344,
1353 (3d Cir. 1991). Here, the Walgreens pharmacists who allegedly made the defamatory
comments testified that they did not do so, thereby creating a genuine dispute of material
fact as to whether the alleged statements were actionable to begin with, and which the jury
3
Dr. Yarus also contends that the jury instructions were erroneously confusing because a
reviewing court is unable “to determine if the jury found that Plaintiff failed to prove that
the Pharmacists made false statements of fact to Plaintiff’s patients . . . or whether the jury
found that their statements were protected opinion . . .” Appellant Br. at 44. Assuming
arguendo that this was error, it was harmless because either finding would compel the jury
to find for Walgreens. See Hill v. Reederei F. Laeisz G.M.B.H., Rostock,
435 F.3d 404,
411 (3d Cir. 2006) (error in jury instruction harmless if “the error did not affect the outcome
of the case” (quoting Forrest v. Beloit Corp.,
424 F.3d 344, 349 (3d Cir. 2005))).
7
resolved as reflected in its verdict. The result therefore did not “shock [the] conscience”
and was not against the weight of the evidence.4 Id.
C. BURDEN OF PROOF
“Truth is an affirmative defense under Pennsylvania law.” Tucker v. Fischbein, 237
F.3d 275, 287 (3d Cir. 2001) (citing 42 Pa. Stat. and Cons. Stat. Ann. § 8343(b)(1)). On
appeal, Dr. Yarus contends that the District Court erred by refusing to give an instruction
that Walgreens had the burden of proving truth – according to him, this omission implicitly
led to requiring him to prove falsity of the defamatory statement. However, we apply plain
error review because Dr. Yarus did not make an objection to the District Court, thereby
waiving his right to assign error on appeal. See Fed. R. Civ. P. 51(d)(1)(B) (“A party may
assign as error: . . . a failure to give an instruction, if that party properly requested it and—
unless the court rejected the request in a definitive ruling on the record—also properly
objected.” (emphasis added)). Here, Walgreens did not substantially advance at trial the
theory that Dr. Yarus was actually being investigated by the DEA – rather, its primary
theory was that the alleged defamatory statements were never spoken. The instruction was
therefore unnecessary and its omission had no effect on the burden of proof – indeed, its
excision was far from plain error. See United States v. Turcks,
41 F.3d 893, 897 (3d Cir.
1994) (plain error in jury instruction occurs when error “affected the outcome of the
District Court proceedings” (quoting United States v. Olano,
507 U.S. 725, 734 (1993))).
4
On appeal, Dr. Yarus included an alleged copy of the jury verdict sheet answered by the
jury which purports that the jury found that the pharmacists made the comments in
question. However, we decline to credit this alleged copy as evidence of the jury’s findings
because it is neither signed nor dated by the jury foreperson.
8
D. STATUTE OF LIMITATIONS
Finally, Dr. Yarus argues that the District Court erred in holding that the defamation
claims relating to the May 1, 2009 and July 23, 2010 incidents were time-barred by
Pennsylvania’s one-year statute of limitations. According to him, the limitations period
was tolled by the doctrine of fraudulent concealment because Walgreens’s counsel’s
reassurance that the remarks on his prescriber profile had been removed “caused [Dr.
Yarus] to relax his vigilance” and therefore prevented him from learning about the
subsequent defamatory statements. Appellant Br. at 47. “[W]e employ a plenary standard
in reviewing orders entered on motions for summary judgment, applying the same standard
as the district court.” Blunt v. Lower Merion Sch. Dist., 767 F.3d 247, 265 (3d Cir. 2014).
We find this argument to be specious. Here, Dr. Yarus’s complaint is clear that his
counsel wrote to Walgreens about the May 1, 2009 comment on May 7, 2009, and about
the May 23, 2010 comment on July 26, 2010. By his own admission, Dr. Yarus was aware
of the alleged defamatory comments on these dates, meaning that the statute of limitations
would have expired at the latest on May 7, 2010 and July 26, 2011, respectively. Dr. Yarus
did not commence this action until November 26, 2013, or well outside the one-year
limitations period. We therefore will affirm the District Court’s grant of summary
judgment.
III. CONCLUSION
For the aforementioned reasons, we will affirm the District Court’s rulings and
orders.
9
